These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 3115617

  • 1. Elevated expression and point mutation of the Ha-ras proto-oncogene in mouse skin tumors promoted by benzoyl peroxide and other promoting agents.
    Pelling JC, Fischer SM, Neades R, Strawhecker J, Schweickert L.
    Carcinogenesis; 1987 Oct; 8(10):1481-4. PubMed ID: 3115617
    [Abstract] [Full Text] [Related]

  • 2. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M, Pazzaglia S, Tanori M, Rebessi S, Di Majo V, Covelli V, Saran A.
    Mutat Res; 2004 Apr 14; 548(1-2):35-45. PubMed ID: 15063134
    [Abstract] [Full Text] [Related]

  • 3. Epidermal papillomas and carcinomas induced in uninitiated mouse skin by tumor promoters alone contain a point mutation in the 61st codon of the Ha-ras oncogene.
    Pelling JC, Neades R, Strawhecker J.
    Carcinogenesis; 1988 Apr 14; 9(4):665-7. PubMed ID: 3128410
    [Abstract] [Full Text] [Related]

  • 4. Elevated expression of Ha-ras is an early event in two-stage skin carcinogenesis in SENCAR mice.
    Pelling JC, Ernst SM, Strawhecker JM, Johnson JA, Nairn RS, Slaga TJ.
    Carcinogenesis; 1986 Sep 14; 7(9):1599-602. PubMed ID: 2427243
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of mouse skin tumorigenesis by dexamethasone occurs through a Ha-ras-independent mechanism.
    Strawhecker JM, Pelling JC.
    Carcinogenesis; 1992 Nov 14; 13(11):2075-80. PubMed ID: 1423878
    [Abstract] [Full Text] [Related]

  • 6. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone.
    Pazzaglia S, Mancuso M, Primerano B, Rebessi S, Biozzi G, Covelli V, Saran A.
    Mol Carcinog; 2001 Feb 14; 30(2):111-8. PubMed ID: 11241758
    [Abstract] [Full Text] [Related]

  • 7. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice.
    Gimenez-Conti IB, Bianchi AB, Fischer SM, Reiners JJ, Conti CJ, Slaga TJ.
    Cancer Res; 1992 Jun 15; 52(12):3432-5. PubMed ID: 1375869
    [Abstract] [Full Text] [Related]

  • 8. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM, Spalding JW, Tennant RW, Smart RC.
    Cancer Res; 1995 Jul 15; 55(14):3171-8. PubMed ID: 7606738
    [Abstract] [Full Text] [Related]

  • 9. Quantitation of early clonal expansion of two mutant 61st codon c-Ha-ras alleles in DMBA/TPA treated mouse skin by nested PCR/RFLP.
    Finch JS, Albino HE, Bowden GT.
    Carcinogenesis; 1996 Dec 15; 17(12):2551-7. PubMed ID: 9006088
    [Abstract] [Full Text] [Related]

  • 10. Characterization of benzo[a]pyrene-initiated mouse skin papillomas for Ha-ras mutations and protein kinase C levels.
    Colapietro AM, Goodell AL, Smart RC.
    Carcinogenesis; 1993 Nov 15; 14(11):2289-95. PubMed ID: 8242857
    [Abstract] [Full Text] [Related]

  • 11. Transplacental induction of a specific mutation in fetal Ha-ras and its critical role in post-natal carcinogenesis.
    Yamasaki H, Hollstein M, Martel N, Cabral JR, Galendo D, Tomatis L.
    Int J Cancer; 1987 Dec 15; 40(6):818-22. PubMed ID: 2891626
    [Abstract] [Full Text] [Related]

  • 12. Alterations in protein kinase C isozymes alpha and beta 2 in activated Ha-ras containing papillomas in the absence of an increase in diacylglycerol.
    Mills KJ, Bocckino SB, Burns DJ, Loomis CR, Smart RC.
    Carcinogenesis; 1992 Jul 15; 13(7):1113-20. PubMed ID: 1638676
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of mezerein-promoted papilloma formation by treatment with 12-O-tetradecanoylphorbol-13-acetate or mezerein prior to initiation.
    Ewing MW, Crysup SE, Phillips JL, Slaga TJ, DiGiovanni J.
    Carcinogenesis; 1988 Mar 15; 9(3):405-10. PubMed ID: 3125993
    [Abstract] [Full Text] [Related]

  • 14. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.
    Rehman I, Lowry DT, Adams C, Abdel-Fattah R, Holly A, Yuspa SH, Hennings H.
    Mol Carcinog; 2000 Apr 15; 27(4):298-307. PubMed ID: 10747294
    [Abstract] [Full Text] [Related]

  • 15. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
    Ewing MW, Conti CJ, Phillips JL, Slaga TJ, DiGiovanni J.
    J Natl Cancer Inst; 1989 May 03; 81(9):676-82. PubMed ID: 2496233
    [Abstract] [Full Text] [Related]

  • 16. v-Ha-ras-induced mouse skin papillomas exhibit aberrant expression of keratin K13 as do their 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate -induced analogues.
    Sutter C, Strickland JE, Welty DJ, Yuspa SH, Winter H, Schweizer J.
    Mol Carcinog; 1991 May 03; 4(6):467-76. PubMed ID: 1724371
    [Abstract] [Full Text] [Related]

  • 17. Characterization of skin tumor promotion by mirex: structure-activity relationships, sexual dimorphism and presence of Ha-ras mutation.
    Moser GJ, Robinette CL, Smart RC.
    Carcinogenesis; 1993 Jun 03; 14(6):1155-60. PubMed ID: 8508502
    [Abstract] [Full Text] [Related]

  • 18. Promoter independence as a feature of most skin papillomas in SENCAR mice.
    Aldaz CM, Conti CJ, Chen A, Bianchi A, Walker SB, DiGiovanni J.
    Cancer Res; 1991 Feb 01; 51(3):1045-50. PubMed ID: 1899044
    [Abstract] [Full Text] [Related]

  • 19. Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR mice.
    Battalora MS, Conti CJ, Aldaz CM, Slaga TJ, Johnston DA, DiGiovanni J.
    Carcinogenesis; 1996 May 01; 17(5):955-60. PubMed ID: 8640943
    [Abstract] [Full Text] [Related]

  • 20. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
    Kim TW, Porter KL, Foley JF, Maronpot RR, Smart RC.
    Mol Carcinog; 1997 Sep 01; 20(1):115-24. PubMed ID: 9328442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.